Patents/Inventors

Yanke Liang

Belmont, MAUS21 patents

23 Patents

US126054502026
C3-carbon Linked Glutarimide Degronimers for Target Protein Degradation
C4 THERAPEUTICS, Inc.
0 cites
US125594922026
BRAF Degraders
C4 Therapeutics, Inc.
0 cites
US124862532025
Therapeutics for the Degradation of Mutant BRAF
C4 THERAPEUTICS, Inc.
0 cites
US124862902025
Isoindolinone and Indazole Compounds for the Degradation of EGFR
C4 THERAPEUTICS, Inc.
0 cites
US124545212025
Targeted Protein Degradation
C4 Therapeutics, Inc.
0 cites
US124417402025
N/o-linked Degrons and Degronimers for Protein Degradation
C4 THERAPEUTICS, Inc.
0 cites
US124212202025
Bicyclic-substituted Glutarimide Cereblon Binders
C4 THERAPEUTICS, Inc.
0 cites
US123981452025
Bicyclic Urea Kinase Inhibitors and Uses Thereof
DANA-FARBER CANCER INSTITUTE, Inc.
0 cites
US123714422025
Isoindolinone and Indazole Compounds for the Degradation of EGFR
C4 Therapeutics, Inc.
0 cites
US122090762025
Imidazolyl Kinase Inhibitors and Uses Thereof
Dana-farber Cancer Institute, Inc.
0 cites
US122090912025
Isoindolinone Derivatives as Selective Allosteric Inhibitors of Egfr Mutant Cancers
Hoffmann-la Roche Inc.
0 cites
US121802252024
N/o-linked Degrons and Degronimers for Protein Degradation
C4 Therapeutics, Inc.
0 cites
US121686632024
0 cites
US121215212024
Uses of Salt-inducible Kinase (SIK) Inhibitors for Treating Osteoporosis
Dana-farber Cancer Institute, Inc.
0 cites
US120764052024
Heterocyclic Degronimers for Target Protein Degradation
C4 Therapeutics, Inc.
0 cites
US120487472024
Substituted Piperidine Degronimers for Target Protein Degradation
C4 Therapeutics, Inc.
0 cites
US120487482024
Spirocyclic Degronimers for Target Protein Degradation
C4 Therapeutics, Inc.
0 cites
US119925312024
C 3 -carbon Linked Glutarimide Degronimers for Target Protein Degradation
C4 Therapeutics, Inc.
0 cites
US118780192024
Uses of Pyrimidopyrimidinones as SIK Inhibitors
Dana-farber Cancer Institute, Inc.
0 cites
US118276362023
Degradation of Cyclin-dependent Kinase 8 (CDK8) by Conjugation of CDK8 Inhibitors with E3 Ligase Ligand and Methods of Use
DANA-FARBER CANCER INSTITUTE, Inc.
0 cites
US117250112023
Bicyclic Urea Kinase Inhibitors and Uses Thereof
THE BROAD INSTITUTE, Inc.
0 cites
US117083542023
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide Compounds
Hoffmann-la Roche Inc.
0 cites
US116739022023
Isoindolinone and Indazole Compounds for the Degradation of EGFR
C4 Therapeutics, Inc.
0 cites